Genflow Biosciences plc
GENF.L · LSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | – | £0 | £0 | £0 |
| - Cash | £0 | £0 | £0 | £0 |
| + Debt | £0 | £0 | £0 | £0 |
| Enterprise Value | – | £0 | £0 | £0 |
| Revenue | £0 | £0 | £0 | £0 |
| % Growth | – | – | – | – |
| Gross Profit | -£0 | -£0 | -£0 | £0 |
| % Margin | – | – | – | – |
| EBITDA | -£0 | -£0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| Net Income | -£0 | -£0 | -£0 | -£0 |
| % Margin | – | – | – | – |
| EPS Diluted | -0.005 | -0.006 | -0.005 | -0.003 |
| % Growth | 16.1% | -21.7% | -35.3% | – |
| Operating Cash Flow | -£0 | -£0 | -£0 | -£0 |
| Capital Expenditures | £0 | -£0 | -£0 | £0 |
| Free Cash Flow | -£0 | -£0 | -£0 | -£0 |